Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy

Retrovirology

Volumn 5, Issue , 2008, Pages

  Chugh, Pauline ^a   Bradel Tretheway, Birgit ^a   Monteiro Filho, Carlos M R ^b   Planelles, Vicente ^b   Maggirwar, Sanjay B ^a   Dewhurst, Stephen ^a   Kim, Baek ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MILTEFOSINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; PROTEIN P53; TRANSACTIVATOR PROTEIN; DRUG DERIVATIVE; PHOSPHORYLCHOLINE; PROTEIN KINASE INHIBITOR;

ANTIVIRAL THERAPY; ARTICLE; CELL DEATH; CELL PROTECTION; CELL STRESS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIFESPAN; MACROPHAGE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELLS, CULTURED; DOWN-REGULATION; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; PHOSPHORYLCHOLINE; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; VIRUS REPLICATION;

EID: 39749152063     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-5-11     Document Type: Article

References (62)

1. Selliah N Finkel TH Biochemical mechanisms of HIV induced T cell apoptosis Cell Death Differ 2001, 8:127-136 10.1038/sj.cdd.4400822 11313714
2. Zhao RY Elder RT Viral infections and cell cycle G2/M regulation Cell Res 2005, 15:143-149 10.1038/sj.cr.7290279 15780175
3. Chugh P Fan S Planelles V Maggirwar SB Dewhurst S Kim B Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line J Mol Biol 2007, 366:67-81 10.1016/j.jmb.2006.11.011 17157319
4. Harrich D Ulich C Garcia-Martinez LF Gaynor RB Tat is required for efficient HIV-1 reverse transcription Embo J 1997, 16:1224-1235 1169721 9135139 10.1093/emboj/16.6.1224
5. Jeang KT Berkhout B Dropulic B Effects of integration and replication on transcription of the HIV-1 long terminal repeat J Biol Chem 1993, 268:24940-24949 8227056
6. Mattson MP Haughey NJ Nath A Cell death in HIV dementia Cell Death Differ 2005, 12(Suppl 1):893-904 10.1038/sj.cdd.4401577 15761472
7. Shi B Raina J Lorenzo A Busciglio J Gabuzda D Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: Potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia J Neurovirol 1998, 4:281-290 9639071
8. Singh IN Goody RJ Dean C Ahmad NM Lutz SE Knapp PE Nath A Hauser KF Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G J Neurovirol 2004, 10:141-151 10.1080/13550280490441103 15204919
9. Kruman Nath A Mattson MP HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress Exp Neurol 1998, 154:276-288 10.1006/ exnr.1998.6958 9878167
10. Zhao ML Kim MO Morgello S Lee SC Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis J Neuroimmunol 2001, 115:182-191 10.1016/S0165-5728(00)00463-X 11282169
11. Polazzi E Levi G Minghetti L Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures J Neuropathol Exp Neurol 1999, 58:825-831 10446807
12. Kan H Xie Z Finkel MS HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappaB activation Am J Physiol Heart Circ Physiol 2000, 279:H3138-43 11087273
13. Kramer-Hammerle S Rothenaigner I Wolff H Bell JE Brack-Werner R Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus Virus Res 2005, 111:194-213 10.1016/ j.virusres.2005.04.009 15885841
14. Lambotte O Deiva K Tardieu M HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era Brain Pathol 2003, 13:95-103 12580549
15. Aquaro S Bagnarelli P Guenci T De Luca A Clementi M Balestra E Calio R Perno CF Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus J Med Virol 2002, 68:479-488 10.1002/jmv.10245 12376954
16. El-Deiry WS Akt takes centre stage in cell-cycle deregulation Nat Cell Biol 2001, 3:E71-3 10.1038/35060148 11231590
17. Osaki M Oshimura M Ito H PI3K-Akt pathway: Its functions and alterations in human cancer Apoptosis 2004, 9:667-676 10.1023/ B:APPT.0000045801.15585.dd 15505410
18. Blond D Raoul H Le Grand R Dormont D Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages J Virol 2000, 74:8904-8912 102085 10982333 10.1128/JVI.74.19.8904-8912.2000
19. Jimenez JL Gonzalez-Nicolas J Alvarez S Fresno M Munoz-Fernandez MA Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide J Virol 2001, 75:4655-4663 114219 11312336 10.1128/JVI.75.10.4655-4663.2001
20. Lim WT Zhang WH Miller CR Watters JW Gao F Viswanathan A Govindan R McLeod HL PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer Oncol Rep 2007, 17:853-857 17342327
21. Hay N The Akt-mTOR tango and its relevance to cancer Cancer Cell 2005, 8:179-183 10.1016/j.ccr.2005.08.008 16169463
22. Newton HB Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis Expert Rev Anticancer Ther 2004, 4:105-128 10.1586/14737140.4.1.105 14748662
23. Hettinger K Vikhanskaya F Poh MK Lee MK de Belle I Zhang JT Reddy SA Sabapathy K c-Jun promotes cellular survival by suppression of PTEN Cell Death Differ 2007, 14:218-229 10.1038/sj.cdd.4401946 16676006
24. Zhang H Liu R Wang R Hong S Xu H Zhang YW Presenilins regulate the cellular level of the tumor suppressor PTEN Neurobiol Aging 2007
25. Edwin F Singh R Endersby R Baker SJ Patel TB The tumor suppressor PTEN is necessary for human Sprouty 2-mediated inhibition of cell proliferation J Biol Chem 2006, 281:4816-4822 10.1074/jbc.M508300200 16371366
26. Henson ES Gibson SB Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: Implications for cancer therapy Cell Signal 2006, 18:2089-2097 10.1016/j.cellsig.2006.05.015 16815674
27. Lin J Adam RM Santiestevan E Freeman MR The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells Cancer Res 1999, 59:2891-2897 10383151
28. van Weeren PC de Bruyn KM de Vries-Smits AM van Lint J Burgering BM Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB J Biol Chem 1998, 273:13150-13156 10.1074/jbc.273.21.13150 9582355
29. del Peso L Gonzalez-Garcia M Page C Herrera R Nunez G Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt Science 1997, 278:687-689 10.1126/science.278.5338.687 9381178
30. Zhou BP Liao Y Xia W Spohn B Lee MH Hung MC Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells Nat Cell Biol 2001, 3:245-252 10.1038/35060032 11231573
31. Zhou BP Liao Y Xia W Zou Y Spohn B Hung MC HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation Nat Cell Biol 2001, 3:973-982 10.1038/ncb1101-973 11715018
32. Kau TR Schroeder F Ramaswamy S Wojciechowski CL Zhao JJ Roberts TM Clardy J Sellers WR Silver PA A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells Cancer Cell 2003, 4:463-476 10.1016/ S1535-6108(03)00303-9 14706338
33. Longo F Marchetti MA Castagnoli L Battaglia PA Gigliani F A novel approach to protein-protein interaction: Complex formation between the p53 tumor suppressor and the HIV Tat proteins Biochem Biophys Res Commun 1995, 206:326-334 10.1006/bbrc.1995.1045 7818536
34. Ariumi Y Kaida A Hatanaka M Shimotohno K Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain Biochem Biophys Res Commun 2001, 287:556-561 10.1006/bbrc.2001.5626 11554765
35. Tang Y Eng C PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner Cancer Res 2006, 66:736-742 10.1158/ 0008-5472.CAN-05-1557 16424003
36. Ulich C Dunne A Parry E Hooker CW Gaynor RB Harrich D Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription J Virol 1999, 73:2499-2508 104497 9971835
37. Kuppuswamy M Subramanian T Srinivasan A Chinnadurai G Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis Nucleic Acids Res 1989, 17:3551-3561 317795 2542902 10.1093/nar/17.9.3551
38. Watson K Edwards RJ HIV-1-trans-activating (Tat) protein: Both a target and a tool in therapeutic approaches Biochem Pharmacol 1999, 58:1521-1528 10.1016/S0006-2952(99)00209-9 10535742
39. Hauber J Malim MH Cullen BR Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein J Virol 1989, 63:1181-1187 247813 2536828
40. Vives E Brodin P Lebleu B A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J Biol Chem 1997, 272:16010-16017 10.1074/jbc.272.25.16010 9188504
41. Subramani S Mulligan R Berg P Expression of the mouse dihydrofolate reductase complementary deoxyribonucleic acid in simian virus 40 vectors Mol Cell Biol 1981, 1:854-864 369369 9279398
42. Igarashi T Brown CR Endo Y Buckler-White A Plishka R Bischofberger N Hirsch V Martin MA Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans Proc Natl Acad Sci U S A 2001, 98:658-663 14644 11136236 10.1073/pnas.021551798
43. Gendelman HE Skillman DR Meltzer MS Interferon alpha (IFN)-macrophage interactions in human immunodeficiency virus (HIV) infection: Role of IFN in the tempo and progression of HIV disease Int Rev Immunol 1992, 8:43-54 10.3109/08830189209056640 1573319
44. Amini S Khalili K Sawaya BE Effect of HIV-1 Vpr on cell cycle regulators DNA Cell Biol 2004, 23:249-260 10.1089/104454904773819833 15142382
45. Andersen JL Planelles V The role of Vpr in HIV-1 pathogenesis Curr HIV Res 2005, 3:43-51 10.2174/1570162052772988 15638722
46. Siliciano JD Siliciano RF A long-term latent reservoir for HIV-1: discovery and clinical implications J Antimicrob Chemother 2004, 54:6-9 10.1093/jac/dkh292 15163657
47. Blankson J Persaud D Siliciano RF Latent reservoirs for HIV-1 Curr Opin Infect Dis 1999, 12:5-11 17035753
48. Bhoopat L Rithaporn TS Khunamornpong S Bhoopat T Taylor CR Thorner PS Cell reservoirs in lymph nodes infected with HIV-1 subtype E differ from subtype B: Identification by combined in situ polymerase chain reaction and immunohistochemistry Mod Pathol 2006, 19:255-263 10.1038/ modpathol.3800527 16341147
49. Popovic M Tenner-Racz K Pelser C Stellbrink HJ van Lunzen J Lewis G Kalyanaraman VS Gallo RC Racz P Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy Proc Natl Acad Sci U S A 2005, 102:14807-14812 1253583 16199516 10.1073/pnas.0506857102
50. Olliaro P Lazdins J Guhl F Developments in the treatment of leishmaniasis and trypanosomiasis Expert Opin Emerg Drugs 2002, 7:61-67 10.1517/14728214.7.1.61 15989536
51. Reddy MA Prasadarao NV Wass CA Kim KS Phosphatidylinositol 3-kinase activation and interaction with focal adhesion kinase in Escherichia coli K1 invasion of human brain microvascular endothelial cells J Biol Chem 2000, 275:36769-36774 10.1074/jbc.M007382200 10973983
52. Marschner N Kotting J Eibl H Unger C Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment Cancer Chemother Pharmacol 1992, 31:18-22 10.1007/BF00695989 1458555
53. Erdlenbruch B Jendrossek V Gerriets A Vetterlein F Eibl H Lakomek M Erucylphosphocholine: Pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration Cancer Chemother Pharmacol 1999, 44:484-490 10.1007/s002800051122 10550569
54. Morgensztern D McLeod HL PI3K/Akt/mTOR pathway as a target for cancer therapy Anticancer Drugs 2005, 16:797-803 10.1097/ 01.cad.0000173476.67239.3b 16096426
55. Momota H Nerio E Holland EC Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo Cancer Res 2005, 65:7429-7435 10.1158/0008-5472.CAN-05-1042 16103096
56. Knowling M Blackstein M Tozer R Bramwell V Dancey J Dore N Matthews S Eisenhauer E A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial Invest New Drugs 2006, 24:435-439 10.1007/s10637-006-6406-7 16528479
57. Ernst DS Eisenhauer E Wainman N Davis M Lohmann R Baetz T Belanger K Smylie M Phase II study of perifosine in previously untreated patients with metastatic melanoma Invest New Drugs 2005, 23:569-575 10.1007/ s10637-005-1157-4 16034524
58. Diamond TL Roshal M Jamburuthugoda VK Reynolds HM Merriam AR Lee KY Balakrishnan M Bambara RA Planelles V Dewhurst S Kim B Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase J Biol Chem 2004, 279:51545-51553 1351161 15452123 10.1074/jbc.M408573200
59. Gjoerup O Zaveri D Roberts TM Induction of p53-independent apoptosis by simian virus 40 small t antigen J Virol 2001, 75:9142-9155 114483 11533178 10.1128/JVI.75.19.9142-9155.2001
60. Varnai P Balla T Visualization of phosphoinositides that bind pleckstrin homology domains: Calcium- and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools J Cell Biol 1998, 143:501-510 10.1083/jcb.143.2.501 9786958
61. Heim A Ebnet C Harste G Pring-Akerblom P Rapid and quantitative detection of human adenovirus DNA by real-time PCR J Med Virol 2003, 70:228-239 10.1002/jmv.10382 12696109
62. Sui Z Sniderhan LF Schifitto G Phipps RP Gelbard HA Dewhurst S Maggirwar SB Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: Implications in HIV type 1 dementia J Immunol 2007, 178:3226-3236 17312171